Prostate Cancer
Geriatric assessment - What should be done and considered before starting therapy of mHSPC and mCRPC?
September 27, 2023
Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia.
September 26, 2023
Rare Genetic Drivers of Lethal Prostate Cancer.
September 26, 2023
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer.
September 26, 2023
Practical Guidance on [177Lu]Lu-PSMA-617 Treatment, Including Radiation Safety, Adverse Event Monitoring, and Patient Counseling.
September 26, 2023
Development and evaluation of the MiCheckĀ® Prostate test for clinically significant prostate cancer.
September 25, 2023
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy.
September 25, 2023
Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer.
September 25, 2023
Threshold for defining PSMA-positivity prior to 177Lu-PSMA therapy: a comparison of [68Ga]Ga-PSMA-11 and [18F]F-DCFPyL in metastatic prostate cancer.
September 25, 2023
Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis.
September 25, 2023
Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers.
September 25, 2023
Androgen receptor variants confer castration resistance in prostate cancer by counteracting antiandrogen-induced ferroptosis.
September 25, 2023
A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling.
September 25, 2023